We examined the mechanism of action of lysophosphatidylcholine (lyso-PC), which is suggested to be involved in the pathogenesis of atherosclerosis and inflamatory disorders, and its interaction with well-known vasoactive compounds such as hydrogen peroxide (H 2 O 2 ), thromboxane A 2 (TX-A 2 ), serotonin (5-HT), angiotensin II (Ang-II), endothelin-1 (ET-1), or urotensin II (U-II) on VSMC proliferation. Growth-arrested rabbit VSMCs were incubated with given concentrations of lyso-PC with H 2 O 2 , TX-A 2 , 5-HT, Ang-II, ET-1, or U-II. [
erophospholipids present in native LDL, 2) but the oxidation of LDL increases this by 5 to 10 fold.
3) Lyso-PC has been shown to have a number of specific effects including the chemotaxis of monocytes and T lymphocytes, 4) the induction of platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) synthesis, 5 ) the inhibition of nitric oxide synthesis and impairment of arterial relaxation, 6) and the induction of vascular smooth muscle cell (VSMC) migration and proliferation. [7] [8] [9] [10] Vasoactive compounds such as hydrogen peroxide (H 2 O 2 ), thromboxane A 2 (TX-A 2 ), serotonin (5-HT), angiotensin II (Ang-II), endothelin-1 (ET-1), and urotensin II (U-II) play a crucial role in the development of atherosclerosis or hypertension by stimulating VSMC proliferation. [11] [12] [13] [14] In this study, we examined the mechanism of action of lyso-PC and its interaction with the vasoactive compounds H 2 O 2 , TX-A 2 , 5-HT, Ang-II, ET-1, or U-II in inducing VSMC proliferation.
METHODS
The present investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Materials: Lyso-PC (palmitoyl), 5-HT (creatinine sulfate), H 2 O 2 , Ang-II, ET-1, U-II, U73122, N-acetylcystein (NAC), diphenylene iodonium (DPI), and PD98059 were purchased from Sigma (St Louis, MO, USA). TX-A 2 (U46619) was obtained from Upjohn. Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), and phosphate-buffered saline (PBS) were purchased from Gibco BRL (Gaithersburg, MD, USA). [ 3 H]Thymidine (specific activity 20 Ci/ mol) was obtained from DuPont-NEN (Boston, MA, USA). Cell culture: VSMCs were isolated from the thoracic aortas of male New Zealand White rabbits (body weight 2.5 to 3 kg, n=35) by the explant method. [11] [12] [13] [14] The intima was first peeled off from the aorta, and then the media was carefully stripped away from the adventitia and placed in a Petri dish containing warmed DMEM (37°C). The medial layer was cut into approximately 1-mm squares, which were transferred into a 25-cm 3 tissue culture flask and barely covered with DMEM supplemented with 20% FBS. The tissue blocks were cultured in a humidified atmosphere (5% CO 2 /95% air) at 37°C. After 3 to 4 weeks, the tissue blocks were removed and the migrated VSMCs were cultured, and then subcultured using trypsinization. The identity of the VSMCs was confirmed by morphological examination and by staining for α-actin. DNA synthesis: DNA synthesis was examined by measurement of [ 3 H]thymidine incorporation into the cellular DNA as described previously. [11] [12] [13] [14] Primary Vol 43 No 4 VSMCs in passage 1 or 2 were seeded onto 35-mm diameter tissue culture plates and grown to semi-confluence in DMEM containing 10% FBS. The growth medium was then replaced with 2 mL of DMEM containing 0.1% FBS and incubated for approximately 72 hours for growth arresting and synchronization. After that, the medium was replaced with DMEM containing 500 µg/mL bovine serum albumin, 10 µg/mL bovine insulin, 20 µg/mL human transferrin, 25 ng/mL selenium, and 100 µM pargyline. Following this, three different experiments were performed, as outlined below. Experiment 1: VSMCs were incubated with lyso-PC (15 µM) in the absence or presence of the phospholipase C inhibitor U73122 (10 µM), the intracellular free radical scavenger NAC (400 µM), the NADPH oxidase inhibitor DPI (1 µM), or the mitogen-activated protein kinase (MAPK) kinase inhibitor PD98059 (10 µM) for 48 hours.
15,16)
Experiment 2: VSMCs were incubated with lyso-PC (5 µM) together with
for 48 hours. Experiment 3: VSMCs were incubated with lyso-PC (5 µM) for 24 hours followed by an incubation with 5-HT (5 µM) for 24 hours. For all three experiments, VSMCs were exposed to [ 3 H]thymidine at a concentration of 1 µCi/plate for the last 5 hours of the 48-hour incubation period with lyso-PC. At the end of the 48-hour incubation with lyso-PC, the medium was removed and the plates were washed with ice-cold PBS. Subsequently 6% trichloroacetic acid was added to the cells, and the acid-insoluble [ 3 H]thymidine was collected on glass fiber filters (Fisher Scientific, Fair Lawn, NJ). The filters were washed with 100% ethanol and air-dried, and [ 3 H]thymidine was measured in a liquid scintillation counter (Packard Instrument Co., Downers Grove, IL). All experiments were performed in quadruplicate and each experiment was repeated at least 3 times. Statistical analysis: Values expressed as mean±SEM were compared by Student's unpaired t-test or ANOVA combined with Dunnett's post-hoc test. A value of P<0.05 was considered to indicate statistical significance.
RESULTS
According to our previous examination, 11) lyso-PC induced a significant increase in [ 3 H]thymidine incorporation with a maximal effect at a concentration of 15 µM (156%), and its effect was significantly inhibited by the phospholipase C inhibitor U73122 (10 µM), the intracellular free radical scavenger NAC (400 µM), and the NADPH oxidase inhibitor DPI (1 µM), but not by the MAPK kinase inhibitor PD98059 (10 µM) (Figure 1 ). H 2 O 2 had a maximal mitogenic effect on VSMCs at a concentration of 5 µM (179%), TX-A 2 at 50 µM (205%), 5-HT at 50 µM (205%), Ang-II at 1.75 µM (202%), ET-1 at 0.1 µM (205%), and U-II at 0.05 µM (161%). Our previous studies have shown that when two compounds were added together, they showed a significant interaction at non-mitogenic concentrations. [11] [12] [13] [14] 16) Therefore, in the present study, we evaluated the interaction between low concentrations of lyso-PC and H 2 O 2 , TX-A 2 , 5-HT, Ang-II, ET-1, or U-II in inducing [ 
DISCUSSION
Lyso-PC is a natural phospholipid that can be generated intracellularly by the action of phospholipase A 2 on membrane phosphatidylcholine, the most abundant cellular phospholipid. 17) Strong evidence supports a role for lyso-PC in the processes of atherosclerosis, inflammation, and wound healing. 6, [17] [18] [19] [20] [21] The lyso-PC content of atherosclerotic arteries is several-fold higher than that of normal vessels. 18.19) It constitutes up to 40% of total lipid in atherogenic lipoproteins such as oxidatively modified LDL and β-migrating very low density lipoprotein. 22) Lyso-PC has been identified as an essential component responsible for some biological activities of these lipoproteins in vivo, such as the chemotactic effect on human monocytes and mitogenic action on macrophages. 4, 21, 23) Additionally, lyso-PC is locally generated by the action on secretory phospholipase A 2 in atherosclerosis and inflammatory lesions.
17)
The addition of lyso-PC to cultured cells can transcriptionally up-regulate the expression of a variety of genes, including cell adhesion molecules (intercellular adhesion molecule 1 and vascular cell adhesion molecule 1), growth factors (PDGF A and B and heparin-binding epidermal growth factor), and vasoprotective enzymes such as nitric-oxide synthase and cyclooxygenase-2. 5, [24] [25] [26] [27] [28] In VSMCs, lyso-PC has been shown to be toxic to cells at high concentrations while lower concentrations induce DNA synthesis and cell growth, which over a narrow concentration range can cause both cytotoxic and proliferative effects. 7, 11) Several investigators have reported that G protein-mediated signal transduction is impaired by high levels of lyso-PC. 29) Further, low concentrations of lyso-PC stimulate smooth muscle growth factors, such as basic FGF. 7, 9) It is also possible that lyso-PC might stimulate VSMC migration at least in part through the release of basic FGF, which is similar to the mechanism involved in the stimulation of VSMC proliferation by lyso-PC. However, others have reported that lyso-PC itself stimulates VSMC proliferation under serum-free conditions. [8] [9] [10] [11] Lyso-PC stimulates phospholipase C, leading to the generation of inositol trisphosphate, which is involved in intracellular Ca 2+ mobilization. 30) Lyso-PC also induces p44/42 MAPK (extracellular signal-regulated kinase [ERK1/2]) activation, c-fos and c-jun mRNA expression, and subsequent enhancement of activator protein-1 binding activity in VSMCs.
31) It has recently been reported that lyso-PC induces the production of reactive oxygen species via NADPH oxidase, 32) and activates the c-jun amino-terminal kinase (JNK). 33) Our previous study has shown that the mitogenic effect of lyso-PC on rabbit VSMCs is mediated via the redox-sensitive (JNK) pathway rather than via the ERK pathway. 34) TX-A 2 , 5-HT, Ang-II, ET-1, and U-II activate Gq protein-coupled receptors (TP, 5-HT 2A , AT 1 , ET A , or GPR14, respectively)-Src family tyrosine kinase-protein kinase C. [12] [13] [14] 35, 36) H 2 O 2 , TX-A 2 , 5-HT, Ang-II, ET-1, and U-II all activate the ERK pathway. 13, 14, 35, 37, 38) In addition to the activation of the ERK pathway for VSMC proliferation, ET-1 activates the JNK pathway, 39) U-II activates the RhoA/ Rho-kinase-dependent pathway, 40) Ang-II activates the JNK pathway and the Janus kinase 2/signal transducer and activator of the transcription 3 pathway, 41, 42) and H 2 O 2 activates the JNK and ERK5 pathways. 43, 44) Together with the activation of the JNK pathway by lyso-PC, activation of the ERK pathway and others by H 2 O 2 , TX-A 2 , 5-HT, Ang-II, ET-1, or U-II may explain the synergistic interaction of lyso-PC with these vasoactive compounds in inducing VSMC proliferation. This interaction may be one of the factors that could contribute to the relatively accelerated development of atherosclerosis in patients with hyperlipidemia and hypertension.
